The navigateAPDS program offers no-charge genetic testing for all blood relatives of patients found to have a pathogenic or likely pathogenic variant of APDS. To qualify, please select the relevant family history criteria, in addition to any other relevant eligibility criteria, when completing a test requisition form and placing an order for a blood relative.
Simply follow the ordering instructions, selecting only the gene(s) you are interested in testing.
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website.
Pharming Group N.V. is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients.